SCHEMBL20907901

SCHEMBL20907901

c1cc(N2CCOCC2)ccc1N1CCCNCC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.55
HTR3E A5X5Y0 3/20 0.55
HTR3B O95264 3/20 0.55
HTR3A P46098 3/20 0.55
HTR3D Q70Z44 3/20 0.55
HTR3C Q8WXA8 3/20 0.55
SIGMAR1 Q99720 3/20 0.55
CHRNB2 P17787 8/20 0.54
CHRNA4 P43681 8/20 0.54
ADRB2 P07550 1/20 0.50
NCF1 P14598 1/20 0.50
PLD1 Q13393 1/20 0.50
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
CYP1A2 P05177 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7082120 0.92 ADRB1 (0.63) ADRB1HTR3EHTR3BHTR3AHTR3D
Bromide SCHEMBL6539744 0.90 ADRB1 (0.61) ADRB1HTR3EHTR3BHTR3AHTR3D
Hydrochloric Acid SCHEMBL28769210 0.90 ADRB1 (0.61) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL17276864 0.83 ADRB1 (0.68) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL3248054 0.82 ADRB1 (0.52) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL26635369 0.82 ADRB1 (0.57) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5235593 0.82 HPGD (0.56) SIGMAR1ALDH1A1MAPTHTTKDM4E
SCHEMBL2175616 0.81 LMNA (0.62) ALDH1A1MEN1MAPTHTTKMT2A
SCHEMBL5570604 0.81 ADRB1 (0.77) ADRB1HTR3EHTR3BHTR3AHTR3D
SCHEMBL24028031 0.81 CHRNB2 (0.58) ADRB1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019073251-A1 LYSYL OXIDASE INHIBITORS THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) 2019-04-18 WO disclosed